Dehydroepiandrosterone sulphate (DHEAS) concentrations stringently regulate fertilisation, embryo development and IVF outcomes: are we looking at a potentially compelling ‘oocyte-related factor’ in oocyte activation?

Documenti analoghi

• Dehydroepiandrosterone (DHEA) supplementation results in supraphysiologic DHEA-S serum levels and progesterone assay interference that may impact clinical management in IVF
  di: Franasiak, Jason M., et al.
  Pubblicazione: (2016)
• Follicular fluid dehydroepiandrosterone sulfate is a credible marker of oocyte maturity and pregnancy outcome in conventional in vitro fertilization cycles
  di: Chimote, Natachandra M., et al.
  Pubblicazione: (2015)
• Periodicity in the levels of serum plasminogen activator inhibitor-1 is a robust prognostic factor for embryo implantation and clinical pregnancy in ongoing IVF cycles
  di: Mehta, Bindu N., et al.
  Pubblicazione: (2014)
• Dehydroepiandrosterone (DHEA) supplementation: an underappreciated cause of premature progesterone elevation detected during frozen embryo transfer
  di: Wu, Frank Shao-Ying, et al.
  Pubblicazione: (2018)
• Follicular-fluid anti-Mullerian hormone (FF AMH) is a plausible biochemical indicator of functional viability of oocyte in conventional in vitro fertilization (IVF) cycles
  di: Mehta, Bindu N, et al.
  Pubblicazione: (2013)